This Biotech Startup Thinks It Can Reverse Vision Loss and Cellular Aging. It’s Testing a Novel Therapy Now
The first human patient has received a dose of Life Biosciences’ sight recovery drug.
🏷️ #reverse
4 headlinesReverse engineering ketamine's effects may lead to new antidepressants
2 points, 0 comments on Hacker News
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
The FDA recently approved the cellular rejuvenation therapy ER-100 for human clinical trials. While vision is the first target, it could have applications for a variety of age-related disease.
The first-ever reverse-aging drug was just injected into a human
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now being tested in humans.